Debt-to-equity of LUMOS PHARMA, INC. from 31 Mar 2018 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
LUMOS PHARMA, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 30 Sep 2024.
  • LUMOS PHARMA, INC. Debt-to-equity for the quarter ending 30 Sep 2024 was 79%, a 211% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

LUMOS PHARMA, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 79% +54% +211% 30 Sep 2024
Q2 2024 52% +31% +143% 30 Jun 2024
Q1 2024 40% +21% +117% 31 Mar 2024
Q4 2023 31% +15% +90% 31 Dec 2023
Q3 2023 26% +11% +77% 30 Sep 2023
Q2 2023 22% +8% +59% 30 Jun 2023
Q1 2023 18% +5% +38% 31 Mar 2023
Q4 2022 16% +4.2% +34% 31 Dec 2022
Q3 2022 14% +2.8% +24% 30 Sep 2022
Q2 2022 14% +1.3% +11% 30 Jun 2022
Q1 2022 13% -7.9% -37% 31 Mar 2022
Q4 2021 12% -19% -61% 31 Dec 2021
Q3 2021 12% -34% -75% 30 Sep 2021
Q2 2021 12% -101% -89% 30 Jun 2021
Q1 2021 21% +243% 31 Mar 2021
Q4 2020 31% +61% 31 Dec 2020
Q3 2020 46% +85% 30 Sep 2020
Q2 2020 114% +395% 30 Jun 2020
Q1 2020 -222% -274% -528% 31 Mar 2020
Q4 2019 -30% -55% -223% 31 Dec 2019
Q3 2019 -39% -57% -317% 30 Sep 2019
Q2 2019 -281% -303% -1403% 30 Jun 2019
Q1 2019 52% +27% +111% 31 Mar 2019
Q4 2018 25% 31 Dec 2018
Q3 2018 18% 30 Sep 2018
Q2 2018 22% 30 Jun 2018
Q1 2018 25% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.